Article
Liver Disease and Risk of Hepatocellular Carcinoma in Children With Mutations in TALDO1.
Hepatology communications - 1 Mar 2022
Grammatikopoulos Tassos, Hadzic Nedim, Foskett Pierre, Strautnieks Sandra, Samyn Marianne, Vara Roshni, Dhawan Anil, Hertecant Jozef, Al Jasmi Fatma, Rahman Obydur, Deheragoda Maesha, Bull Laura N, Thompson Richard J
Abstract excerpt
Mutations in the transaldolase 1 (TALDO1) gene have been described in a limited number of cases. Several organs can be affected and clinical manifestations are variable, but often include liver dysfunction and/or hepatosplenomegaly. We report 4 patients presenting with liver disease: 2 with early-onset hepatocellular carcinoma (HCC). Patients with cholestasis and mutations in TALDO1 were identified by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
